Generation of an induced pluripotent stem cell line (IGGi002A) from nasal cells of a cystic fibrosis patient homozygous for the G542X-CFTR mutation.

Autor: Dębczyński M; II Department of Lung Diseases and Tuberculosis, Medical University of Bialystok, Bialystok, Poland., Mojsak D; II Department of Lung Diseases and Tuberculosis, Medical University of Bialystok, Bialystok, Poland., Tamburro S; Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genoa, Italy., Baldassari S; Unit of Medical Genetics, IRCCS Istituto Giannina Gaslini, Genova, Italy., Musante I; Unit of Medical Genetics, IRCCS Istituto Giannina Gaslini, Genova, Italy., Casciaro R; Cystic Fibrosis Centre, IRCCS Istituto Giannina Gaslini, Genova, Italy., Ciciriello F; Cystic Fibrosis Unit, Department of Pediatric Subspecialties, Bambino Gesù Children's Hospital, IRCCS-Rome, Italy., Zara F; Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genoa, Italy; Unit of Medical Genetics, IRCCS Istituto Giannina Gaslini, Genova, Italy., Scudieri P; Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genoa, Italy; Unit of Medical Genetics, IRCCS Istituto Giannina Gaslini, Genova, Italy. Electronic address: paolo.scudieri@unige.it., Gorrieri G; Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genoa, Italy.

Publikováno v: Stem cell research [Stem Cell Res] 2023 Oct; Vol. 72, pp. 103232. Date of Electronic Publication: 2023 Oct 18.

Genome-engineering technologies for modeling and treatment of cystic fibrosis.

Autor: Dębczyński M; II Department of Lung Diseases and Tuberculosis, Medical University of Bialystok, Bialystok, Poland. Electronic address: michal.debczynski@umb.edu.pl., Mojsak D; II Department of Lung Diseases and Tuberculosis, Medical University of Bialystok, Bialystok, Poland., Minarowski Ł; II Department of Lung Diseases and Tuberculosis, Medical University of Bialystok, Bialystok, Poland., Maciejewska M; II Department of Lung Diseases and Tuberculosis, Medical University of Bialystok, Bialystok, Poland., Lisowski P; II Department of Lung Diseases and Tuberculosis, Medical University of Bialystok, Bialystok, Poland; Institute of Genetics and Animal Biotechnology, Polish Academy of Sciences, Magdalenka, Poland; Department of Psychiatry, Charité - Universitätmedizin Berlin, Berlin, Germany; Berlin Institute for Medical Systems Biology (BIMSB), Max-Delbrück-Center for Molecular Medicine (MDC), Berlin, Germany., Mróz RM; II Department of Lung Diseases and Tuberculosis, Medical University of Bialystok, Bialystok, Poland.

Publikováno v: Advances in medical sciences [Adv Med Sci] 2023 Mar; Vol. 68 (1), pp. 111-120. Date of Electronic Publication: 2023 Mar 12.

A 75-Year-Old Female Smoker with Advanced Small-Cell Lung Cancer and Eastern Cooperative Oncology Group Performance Status 2 who Responded to Combination Immunochemotherapy with Atezolizumab, Etoposide, and Carboplatin.

Autor: Dębczyński M; Second Department of Lung Diseases and Tuberculosis, Medical University of Białystok, Białystok, Poland., Mojsak D; Second Department of Lung Diseases and Tuberculosis, Medical University of Białystok, Białystok, Poland., Kuklińska B; Second Department of Lung Diseases and Tuberculosis, Medical University of Białystok, Białystok, Poland., Mróz RM; Second Department of Lung Diseases and Tuberculosis, Medical University of Białystok, Białystok, Poland.

Publikováno v: The American journal of case reports [Am J Case Rep] 2022 Aug 11; Vol. 23, pp. e936536. Date of Electronic Publication: 2022 Aug 11.

Current state of knowledge on immunotherapy in ECOG PS 2 patients. A systematic review.

Autor: Mojsak D; 2nd Department of Lung Diseases and Tuberculosis, Medical University of Bialystok, Bialystok, Poland. Electronic address: damian.mojsak@umb.edu.pl., Kuklińska B; 2nd Department of Lung Diseases and Tuberculosis, Medical University of Bialystok, Bialystok, Poland., Minarowski Ł; 2nd Department of Lung Diseases and Tuberculosis, Medical University of Bialystok, Bialystok, Poland., Mróz RM; 2nd Department of Lung Diseases and Tuberculosis, Medical University of Bialystok, Bialystok, Poland.

Publikováno v: Advances in medical sciences [Adv Med Sci] 2021 Sep; Vol. 66 (2), pp. 381-387. Date of Electronic Publication: 2021 Jul 24.

E-cigarette use among young adults in Poland: Prevalence and characteristics of e-cigarette users.

Autor: Jankowski M; School of Public Health, Centre of Postgraduate Medical Education, Warsaw Poland., Minarowski Ł; 2nd Department of Lung Diseases and Tuberculosis, Medical University of Bialystok, Białystok, Poland. Electronic address: lukasz.minarowski@umb.edu.pl., Mróz RM; 2nd Department of Lung Diseases and Tuberculosis, Medical University of Bialystok, Białystok, Poland., Guziejko K; 2nd Department of Lung Diseases and Tuberculosis, Medical University of Bialystok, Białystok, Poland., Mojsak D; 2nd Department of Lung Diseases and Tuberculosis, Medical University of Bialystok, Białystok, Poland., Poznański M; Department of General and Oncological Pneumonology, First Chair of Internal Diseases, Medical University of Lodz, Lodz, Poland., Zielonka TM; Department of Family Medicine, Warsaw Medical University, Warsaw, Poland., Rachel M; Department of Human Physiology and Pathophysiology, Faculty of Medicine, University of Rzeszów, Rzeszow, Poland., Kornicki K; Department of General and Oncological Pneumonology, First Chair of Internal Diseases, Medical University of Lodz, Lodz, Poland., Pepłowska P; Department of Family Medicine, Warsaw Medical University, Warsaw, Poland., Bielewicz K; Department of Human Physiology and Pathophysiology, Faculty of Medicine, University of Rzeszów, Rzeszow, Poland., Piotrowski W; Department of Pneumology and Allergy, First Chair of Internal Diseases, Medical University of Lodz, Lodz, Poland., Ziobroń A; Department of Human Physiology and Pathophysiology, Faculty of Medicine, University of Rzeszów, Rzeszow, Poland., Pękala-Wojciechowska A; Department of Clinical Pharmacology, First Chair of Internal Diseases, Medical University of Lodz, Lodz, Poland., Zborowski J; Department of Human Physiology and Pathophysiology, Faculty of Medicine, University of Rzeszów, Rzeszow, Poland., Shpakou A; Department of Sports Medicine and Rehabilitation, YankaKupala State University of Grodno, Grodno, Belarus., Skoczyński S; Department of Pneumonology, Faculty of Medical Sciences in Katowice, Medical University of Silesia in Katowice, Katowice, Poland., Majek P; Department of Epidemiology, Faculty of Medical Sciences in Katowice, Medical University of Silesia in Katowice, Katowice, Poland., Lawson J; Canadian Centre for Health and Safety in Agriculture, College of Medicine, University of Saskatchewan, Saskatoon, Canada; Department of Medicine, College of Medicine, University of Saskatchewan, Saskatoon, Canada., Zejda JE; Department of Epidemiology, Faculty of Medical Sciences in Katowice, Medical University of Silesia in Katowice, Katowice, Poland., Brożek GM; Department of Epidemiology, Faculty of Medical Sciences in Katowice, Medical University of Silesia in Katowice, Katowice, Poland.

Publikováno v: Advances in medical sciences [Adv Med Sci] 2020 Sep; Vol. 65 (2), pp. 437-441. Date of Electronic Publication: 2020 Sep 24.